Home

Myricetin

Myricetin

Specifications

529-44-2CAS Number
208-463-2EC Number
3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-oneIUPAC Name
C15H10O8Chemical Formula
318.23 g/molMolecular Weight
myricetin; 529-44-2; Cannabiscetin; Myricetol; 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one; Myricitin; 3,3',4',5,5',7-Hexahydroxyflavone; 3,5,7,3',4',5'-Hexahydroxyflavone; 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one; 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-4-one; delphidenolon 1575; 3,3',4,4',5',7-Hexahydro-2-phenyl-4H-chromen-4-one; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-; 76XC01FTOJ; NSC-407290; DTXSID8022400; FLAVONE, 3,3',4',5,5',7-HEXAHYDROXY-; CHEBI:18152; RefChem:6547; DTXCID002400; 3,4,5-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-7-one; 208-463-2; MFCD00006827; NSC 407290; Myricetin (Standard); NSC407290; CHEMBL164; MYC; SMR001233193; CCRIS 5838; SR-01000076005; EINECS 208-463-2; 3,3,4,4,5,7-Hexahydro-2-phenyl-4H-chromen-4-one; UNII-76XC01FTOJ; BRN 0332331; myricetone; Cannabiscetin;; Myrc; Myricetol;; HSDB 7682; 4gqr; Prestwick_342; Spectrum_001501; SpecPlus_000531; MYRICETIN [MI]; Cannabiscetin (Standard); MYRICETIN [HSDB]; Prestwick0_000465; Prestwick1_000465; Prestwick2_000465; Prestwick3_000465; Spectrum4_001272; Spectrum5_000692; Lopac-M-6760; Myricetin (Cannabiscetin); Myricetin from Myrica cerifera leaf and bark; BIDD:PXR0079; Lopac0_000740; SCHEMBL19302; BSPBio_000570; KBioGR_001884; KBioSS_001981; MLS002153825; MLS006010718; BIDD:ER0142; DivK1c_006627; Myricetin, analytical standard; SPBio_002509; BPBio1_000628; MEGxp0_000357; orb1310476; orb3140813; SCHEMBL29357150; ACon1_000267; BDBM15236; cid_5281672; GTPL13074; KBio1_001571; KBio2_001981; KBio2_004549; KBio2_007117; MSK7402; 2o63; CHEBI: 18152; REGID_for_CID_5281672; HMS1569M12; HMS2096M12; HMS2231L04; HMS3262C22; HMS3656I05; Cannabiscetin; Myricetol; Myricitin; Myricetin, >=96.0% (HPLC); Myricetin, >=96.0%, crystalline; SAI_0014; TNP00286; Tox21_500740; HB0434; HY-15097R; LMPK12110001; STL284709; 3,7,3',4',5'-Hexahydroxyflavone; AKOS015903103; AC-4533; CCG-204825; CS-6221; DB02375; EBC-221043; FM26112; KS-5268; LP00740; SDCCGSBI-0050718.P003; SDCCGSBI-0050718.P008; 3,3',4',5,5',7-hexOH-Flavone; 3,3?,4?,5,5?,7-Hexahydroxyflavone; Flavone,3',4',5,5',7-hexahydroxy-; NCGC00015697-01; NCGC00015697-02; NCGC00015697-03; NCGC00015697-04; NCGC00015697-05; NCGC00015697-06; NCGC00015697-07; NCGC00015697-08; NCGC00015697-09; NCGC00015697-10; NCGC00015697-11; NCGC00015697-12; NCGC00015697-13; NCGC00015697-14; NCGC00015697-19; NCGC00015697-25; NCGC00094083-01; NCGC00094083-02; NCGC00094083-03; NCGC00094083-04; NCGC00179517-01; NCGC00179517-02; NCGC00261425-01; CAS-529-44-2; DA-65734; HY-15097; NCI60_003870; ST057235; SY051702; EU-0100740; M2131; M9367; NS00014642; SW196616-2; T0579; M 6760; S00115; 3,3',4',5,5',7-hexahydroxy-(8CI)- flavone; F239118; Q951449; C07E0ED2-ABF6-4BD3-A2B2-A98CAEF20FD1; Myricetin, primary pharmaceutical reference standard; SR-01000076005-1; SR-01000076005-6; BRD-K43149758-001-04-5; BRD-K43149758-001-22-7; BRD-K43149758-001-23-5; 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one #; 4H-1-Benzopyran-4-one,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-Synonyms